Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
852 Modified-epitope-based vaccine (OSE2101) combined with anti-PD-1/IL-7v bispecific antibody sustains long-lasting tumor specific antigen memory T cell response in vivo
Compose a Response to This Article
Other responses
No responses have been published for this article.
